Tegoprazan Impurity 14 | CAS 2168520-25-8 - Request Quote
Tegoprazan Impurity 14
| SZ CAT No: | SZ-T098017 |
| CAS No | 2168520-25-8 |
| Mol.F. | C11H13N3O2 |
| Mol.Wt. | 219.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Tegoprazan Impurity 14 is chemically 4-Hydroxy-N,N,2-trimethyl-1H-benzo[d]imidazole-6-carboxamide. Tegoprazan Impurity 14 is supplied with detailed characterization data compliant with regulatory guideline. Tegoprazan Impurity 14 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Tegoprazan.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2168520-25-8
Purchase 2168520-25-8
Order 2168520-25-8
Enquire 2168520-25-8
price of 2168520-25-8
2168520-25-8 Supplier
2168520-25-8 Manufacturer
2168520-25-8 Exporter
buy high quality Tegoprazan Impurity 14
Purchase Tegoprazan Impurity 14
Tegoprazan Impurity 14 suppliers
Tegoprazan Impurity 14 manufacturers
Tegoprazan Impurity 14 price
Order Tegoprazan Impurity 14
Enquire Tegoprazan Impurity 14
Tegoprazan Impurity 14 cost
Tegoprazan Impurity 14 Supplier
Tegoprazan Impurity 14 Distributor
Tegoprazan Impurity 14 for Method Validation
Tegoprazan Reference Standard
Tegoprazan Impurity 14 for ANDA Filing
Tegoprazan Impurity 14 for Forced Degradation Studies
Tegoprazan Impurity 14 Identification Standards
Tegoprazan Impurity 14 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


